vs

Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

DYNEX CAPITAL INC is the larger business by last-quarter revenue ($43.5M vs $41.8M, roughly 1.0× Neuronetics, Inc.). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 85.7%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 54.9%).

Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

DX vs STIM — Head-to-Head

Bigger by revenue
DX
DX
1.0× larger
DX
$43.5M
$41.8M
STIM
Growing faster (revenue YoY)
DX
DX
+445.6% gap
DX
531.3%
85.7%
STIM
Faster 2-yr revenue CAGR
DX
DX
Annualised
DX
75.8%
54.9%
STIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DX
DX
STIM
STIM
Revenue
$43.5M
$41.8M
Net Profit
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
-17.2%
Revenue YoY
531.3%
85.7%
Net Profit YoY
43.2%
EPS (diluted)
$1.59
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DX
DX
STIM
STIM
Q4 25
$43.5M
$41.8M
Q3 25
$30.6M
$37.3M
Q2 25
$23.1M
$38.1M
Q1 25
$17.1M
$32.0M
Q4 24
$22.5M
Q3 24
$18.5M
Q2 24
$16.4M
Q1 24
$-3.2M
$17.4M
Net Profit
DX
DX
STIM
STIM
Q4 25
$-7.2M
Q3 25
$150.4M
$-9.0M
Q2 25
$-13.6M
$-10.1M
Q1 25
$-3.1M
$-12.7M
Q4 24
$-12.7M
Q3 24
$-13.3M
Q2 24
$-9.8M
Q1 24
$40.1M
$-7.9M
Gross Margin
DX
DX
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
DX
DX
STIM
STIM
Q4 25
-12.1%
Q3 25
-19.6%
Q2 25
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
-51.7%
Q1 24
-39.4%
Net Margin
DX
DX
STIM
STIM
Q4 25
-17.2%
Q3 25
491.3%
-24.3%
Q2 25
-58.8%
-26.6%
Q1 25
-18.0%
-39.6%
Q4 24
-56.4%
Q3 24
-72.0%
Q2 24
-59.8%
Q1 24
-1256.8%
-45.2%
EPS (diluted)
DX
DX
STIM
STIM
Q4 25
$1.59
$-0.10
Q3 25
$1.08
$-0.13
Q2 25
$-0.14
$-0.15
Q1 25
$-0.06
$-0.21
Q4 24
$-0.34
Q3 24
$-0.44
Q2 24
$-0.33
Q1 24
$0.64
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DX
DX
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$531.0M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$2.5B
$22.4M
Total Assets
$17.3B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DX
DX
STIM
STIM
Q4 25
$531.0M
$28.1M
Q3 25
$491.0M
$28.0M
Q2 25
$387.5M
$11.0M
Q1 25
$327.4M
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Q1 24
$295.7M
$47.7M
Total Debt
DX
DX
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
DX
DX
STIM
STIM
Q4 25
$2.5B
$22.4M
Q3 25
$2.0B
$27.4M
Q2 25
$1.6B
$27.1M
Q1 25
$1.4B
$35.5M
Q4 24
$27.7M
Q3 24
$9.4M
Q2 24
$19.4M
Q1 24
$958.5M
$27.7M
Total Assets
DX
DX
STIM
STIM
Q4 25
$17.3B
$141.6M
Q3 25
$14.2B
$145.5M
Q2 25
$11.3B
$134.7M
Q1 25
$9.0B
$142.0M
Q4 24
$140.9M
Q3 24
Q2 24
$96.8M
Q1 24
$6.3B
$103.8M
Debt / Equity
DX
DX
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DX
DX
STIM
STIM
Operating Cash FlowLast quarter
$120.8M
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DX
DX
STIM
STIM
Q4 25
$120.8M
$908.0K
Q3 25
$68.3M
$-785.0K
Q2 25
$31.9M
$-3.5M
Q1 25
$6.4M
$-17.0M
Q4 24
$-8.6M
Q3 24
$-5.4M
Q2 24
$-5.0M
Q1 24
$-17.1M
$-12.0M
Free Cash Flow
DX
DX
STIM
STIM
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
Q1 24
$-12.4M
FCF Margin
DX
DX
STIM
STIM
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Q1 24
-71.1%
Capex Intensity
DX
DX
STIM
STIM
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Q1 24
2.2%
Cash Conversion
DX
DX
STIM
STIM
Q4 25
Q3 25
0.45×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons